奎平与胰腺炎有关:一个现实世界的药监测研究
1Department of Medicine, University of British Columbia, 2194 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada.
Journal of affective disorders
|January 11, 2025
概括
奎蒂亚平是一种抗精神病药物,与胰腺炎的显著更高风险有关,大约是其他药物的30倍. 由于这种潜在的风险,医疗保健提供者在开药时应谨慎.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 胃肠病学 胃肠病学
背景情况:
- 奎蒂亚平是一种广泛处方的非典型抗精神病药物,用于治疗精神分裂症和双相情感障碍.
- 之前的观察表明,奎胺使用与胰腺炎之间存在潜在联系.
研究的目的:
- 量化奎胺使用与胰腺炎发病率之间的关联.
- 与其他药物相比,评估服用奎平的患者报告胰腺炎的频率.
主要方法:
- 利用了FDA不良事件报告系统 (FAERS) 的数据.
- 采用不成比例分析,包括比例报告比率 (PRR) 和报告概率比率 (ROR).
主要成果:
- 在奎蒂亚平和胰腺炎之间发现了显著的关联.
- 相对报告率为30.708,表明风险大幅增加.
- 报告几率比 (ROR) 为32.990表明胰腺炎的风险是kvetiapine的30倍以上.
结论:
- 奎蒂阿平的使用与患胰腺炎的相当大风险有关.
- 医生在开药时应保持警,尤其是对患有危险因素如高甘油三血症的患者.
- 需要进一步的研究来确认因果关系并探索缓解策略.
相关概念视频
Pharmacovigilance
770
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
770
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Dipeptidyl Peptidase 4 Inhibitors
165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70


